Qiagen Q3 profit surges on COVID-19 testing demand

Comments Off on Qiagen Q3 profit surges on COVID-19 testing demand
A logo of a testing company Qiagen is seen as Economy Minister Andreas Pinkwart and Health Minister Karl-Josef Laumann of the German state Northrhine Westphalia visit Qiagen’s facility, in Hilden, Germany, September 8, 2020. REUTERS/Leon Kuegeler

(Reuters) – U.S.-German genetic testing specialist Qiagen reported a surge in third-quarter profit on Wednesday, boosted by higher demand for its coronavirus tests amid a rise in infections due to the fast-spreading Delta variant.

Net income rose to $0.57 per share from $0.07 per share, a year earlier.

Source: Read Full Article

Related posts:
  1. Results from the COBRA-REDUCE trial reported
  2. How to manage post-Election Day stress, anxiety as results roll in
  3. 2 Regular Guys Trained Their Abs for 30 Days and Shared the Results
  4. Roche reports promising results from anti-COVID cocktail